PTC Therapeutics, Inc.
Biotechnology ResearchUnited States1001-5000 Employees
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
Investment Opportunities Multiple recent investments indicate potential interest from institutional investors like Burney Co., Allspring Global Investments, Rathbones Group Plc, and others, presenting an opportunity for partnership or collaboration.
Market Expansion through Partnerships Partnership with Royalty Pharma plc for Evrysdi® royalty agreement up to $1.5 billion showcases potential for market expansion and revenue growth through strategic collaborations.
Uncovered Sales Opportunities Recent investigation into securities law violations may lead to opportunities to engage legally inclined investors seeking potentially undervalued stocks or companies with long-term growth potential.
Competitive Positioning Comparison with similar companies like Sarepta Therapeutics, Novartis, Pfizer and others indicates a strong employee base and revenue range, highlighting competitive positioning and potential avenues for differentiation in the market.
Revenue Potential With revenue estimates ranging from $100 million to $1 billion, PTC Therapeutics has substantial revenue potential, making it an attractive target for sales professionals looking to capitalize on a growing market segment.
PTC Therapeutics, Inc. uses 8 technology products and services including Power BI, Microsoft Power BI, Varnish, and more. Explore PTC Therapeutics, Inc.'s tech stack below.
PTC Therapeutics, Inc. Email Formats | Percentage |
FLast@ptcbio.com | 94% |
FirstLast@ptcbio.com | 3% |
First.Last@ptcbio.com | 2% |
FMiddleLast@ptcbio.com | 1% |
Biotechnology ResearchUnited States1001-5000 Employees
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
PTC Therapeutics, Inc. has raised a total of $1B of funding over 15 rounds. Their latest funding round was raised on Oct 27, 2022 in the amount of $1B.
PTC Therapeutics, Inc.'s revenue is in the range of $100M$1B
PTC Therapeutics, Inc. has raised a total of $1B of funding over 15 rounds. Their latest funding round was raised on Oct 27, 2022 in the amount of $1B.
PTC Therapeutics, Inc.'s revenue is in the range of $100M$1B
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.